Disease/Infection News

RSS

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

IgA and IgG in human breast milk and blood were assessed for their activity against SARS-CoV-2 and SARS-CoV-1, as well as four other prevalent HCoVs.

28 Jun 2022

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

In a recent study posted to the bioRxiv* pre-print server, researchers in the United States described a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) SP1-77 that broadly neutralized its multiple variants of concern (VOCs).

28 Jun 2022

Should monkeypox be considered a sexual transmitted infection?

The present monkeypox outbreak is marked by sustainable human-to-human transmission.

28 Jun 2022

COVID-19 mortality rates by race and ethnicity in U.S. state prisons

In a recent study posted to the medRxiv* pre-print server, researchers estimated the rate of coronavirus disease 2019 (COVID-19) cases and deaths among individuals incarcerated in the state prisons of the United States (U.S.).

28 Jun 2022

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

New CDC data published ahead of National HIV Testing Day (Monday, June 27) show a sharp decrease in the number of CDC-funded HIV tests administered in health care and non-health-care settings (43% and 50%, respectively) from 2019 to 2020, the first year of the COVID-19 pandemic.

28 Jun 2022

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland.

28 Jun 2022

Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Scientists from China have recently deciphered the genetic network and biological mechanisms associated with COVID-19 myocarditis using bioinformatic methods.

28 Jun 2022

Low rates of severe COVID-19 found in patients treated with monoclonal antibodies during delta surge

A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low rates of severe disease, hospitalization, ICU admission and mortality, according to Mayo Clinic researchers.

28 Jun 2022

The mental health status and menstrual changes in hospitalized female COVID-19 patients

Researchers assessed the changes in the menstrual cycle and mental states among female coronavirus disease 2019 (COVID-19) patients.

28 Jun 2022

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

28 Jun 2022

Highly antibiotic-resistant strain of MRSA on pigs is capable of rapidly adapting to human hosts

A new study has found that a highly antibiotic-resistant strain of the superbug MRSA – methicillin resistant Staphylococcus aureus – has emerged in livestock in the last 50 years, probably due to widespread antibiotic use in pig farming.

28 Jun 2022

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

Researchers performed genomic comparisons between alphacoronaviruses (αCoVs) and betacoronaviruses (βCoVs) originating from South Korean Bats.

28 Jun 2022

Evolution of SARS-CoV-2 genomes based on continuing positive selection

Researchers hypothesized that ongoing positive selection strongly influences SARS-CoV-2 genomes, which plays an important role in shaping the dynamics of the COVID-19 pandemic.

28 Jun 2022

Effectiveness of monoclonal antibodies and directly acting antivirals against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages

Researchers assessed the in vivo effectiveness of monoclonal antibodies and directly acting antiviral agents against the SARS-CoV-2 Omicron BA.1 and BA.2 sublineages.

28 Jun 2022

The potential of DNA-based SARS-CoV-2 vaccine candidates

Researchers evaluated the immunogenicity of DNA-based candidate vaccines against SARS-CoV-2 in mice.

28 Jun 2022

A data commons to accelerate research in COVID and long-COVID

In a recent study posted to the medRxiv* pre-print server, researchers in the United States developed a pandemic response commons (PRC) called the Chicagoland coronavirus disease 2019 (COVID-19) commons (CCC). The CCC served Chicago, the state of Illinois, and surrounding regions in the United States (US).

28 Jun 2022

Cell-based assay highlights differences in antibody neutralizing capacity for SARS-CoV-2 variants

A recent study by scientists at Celentyx Ltd, the University of Birmingham, and the University of Warwick and posted to the bioRxiv* preprint server illustrated a cell-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein attachment assay.

28 Jun 2022

A cancer patient who had SARS-CoV-2 for over eight months

In a recent study posted to the medRxiv* pre-print server, researchers in Israel described the case of a severely immunocompromised cancer patient who developed a chronic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

28 Jun 2022

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

A recent study posted to the bioRxiv* preprint server assessed whether niclosamide could be employed in coronavirus disease 2019 (COVID-19) therapy.

28 Jun 2022

In 1st year of pandemic, COVID vaccines saved 20M lives

In a recent study published in The Lancet journal, researchers at Imperial College London quantified the impact of the coronavirus disease 2019 (COVID-19) vaccination programs in 185 countries and territories between December 8, 2020, and December 8, 2021.

28 Jun 2022

Disease/Infection News

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

Should monkeypox be considered a sexual transmitted infection?

COVID-19 mortality rates by race and ethnicity in U.S. state prisons

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Low rates of severe COVID-19 found in patients treated with monoclonal antibodies during delta surge

The mental health status and menstrual changes in hospitalized female COVID-19 patients

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

Highly antibiotic-resistant strain of MRSA on pigs is capable of rapidly adapting to human hosts

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

Evolution of SARS-CoV-2 genomes based on continuing positive selection

Effectiveness of monoclonal antibodies and directly acting antivirals against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages

The potential of DNA-based SARS-CoV-2 vaccine candidates

A data commons to accelerate research in COVID and long-COVID

Cell-based assay highlights differences in antibody neutralizing capacity for SARS-CoV-2 variants

A cancer patient who had SARS-CoV-2 for over eight months

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

In 1st year of pandemic, COVID vaccines saved 20M lives

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News